Get started
Author

Yuri Ochi

Observed name: Y Ochi
ORCID: 0000-0002-3307-8555
Observed ORCID: 0000-0002-3307-8555
OpenAlex ID: A5029118698
Early Experience of Tafamidis Treatment in Japanese Patients With Wild-Type Transthyretin Cardiac Amyloidosis From the Kochi Amyloidosis Cohort
2022 · Yuri Ochi, Toru Kubo, et al. · Circulation Journal · 48
PDF
Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy
2016 · Toru Kubo, Yuri Ochi, et al. · Journal of Cardiology · 41
PDF
Patients’ Characteristics and Clinical Course of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort ― Results From Kochi RYOMA Study ―
2018 · Toru Kubo, Takayoshi Hirota, et al. · Circulation Journal · 35
PDF
Tenosynovial and Cardiac Transthyretin Amyloidosis in Japanese Patients Undergoing Carpal Tunnel Release
2021 · Kenta Sugiura, Hiroki Kozuki, et al. · Circulation Reports · 27
PDF
Elevation of High-Sensitivity Cardiac Troponin T and Left Ventricular Remodelling in Hypertrophic Cardiomyopathy
2020 · Toru Kubo, Yuri Ochi, et al. · ESC Heart Failure · 26
PDF
Wild-Type Transthyretin Amyloidosis in Female Patients ― Consideration of Sex Differences ―
2021 · Yuri Ochi, Toru Kubo, et al. · Circulation Reports · 23
PDF
Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy
2020 · Yasuteru Nakashima, Toru Kubo, et al. · Circulation Journal · 23
PDF
Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and 99mTc-pyrophosphate scintigraphy
2019 · Yuri Ochi, Toru Kubo, et al. · Journal of Cardiology · 20
PDF
Prospective Multicenter Screening With High-Sensitivity Cardiac Troponin T for Wild-Type Transthyretin Cardiac Amyloidosis in Outpatient and Community-Based Settings
2024 · Naoki Arima, Yuri Ochi, et al. · Circulation Journal · 19
PDF
Clinical Profile of Thromboembolic Events in Patients With Hypertrophic Cardiomyopathy in a Regional Japanese Cohort ― Results From Kochi RYOMA Study ―
2019 · Takayoshi Hirota, Toru Kubo, et al. · Circulation Journal · 17
PDF
A Validation Study of the Mayo Clinic Phenotype-Based Genetic Test Prediction Score for Japanese Patients With Hypertrophic Cardiomyopathy
2021 · Toshihiro Moriki, Toru Kubo, et al. · Circulation Journal · 16
PDF
Clinical Significance of New-Onset Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
2021 · Toru Kubo, Yuichi Baba, et al. · ESC Heart Failure · 15
Reconsideration of the cut-off value of angiotensin-converting enzyme for screening of sarcoidosis in Japanese patients
2019 · Yuichi Baba, Toru Kubo, et al. · Journal of Cardiology · 15
Validation of the Kumamoto criteria for prediction of 99m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi
2020 · Yuri Ochi, Toru Kubo, et al. · Journal of Cardiology · 13
Very Long-Term Prognosis in Patients with Hypertrophic Cardiomyopathy: A Longitudinal Study with a Period of 20 Years
2022 · Kenta Sugiura, Toru Kubo, et al. · ESC Heart Failure · 12
PDF
Unveiling Clinical and Genetic Distinctions in Pure‐Apical Versus Distal‐Dominant Apical Hypertrophic Cardiomyopathy
2025 · Kenta Sugiura, Toru Kubo, et al. · Journal of the American Heart Association · 10
Prediction of Medium-Term Mortality in Japanese Patients With Wild-Type Transthyretin Amyloidosis
2020 · Yuri Ochi, Toru Kubo, et al. · Circulation Reports · 10
PDF
A case report of an uncommon presentation of 99mtechnetium pyrophosphate scintigraphy in transthyretin cardiac amyloidosis: A potential diagnostic pitfall, pseudo-positive or pseudo-negative?
2019 · Yuri Ochi, Toru Kubo, et al. · Journal of Cardiology Cases · 10
PDF
Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I
2020 · Kenta Sugiura, Toru Kubo, et al. · Molecular Genetics and Metabolism Reports · 9
PDF
High-sensitivity Cardiac Troponin T Is a Useful Biomarker for Predicting the Prognosis of Patients with Systemic Sarcoidosis Regardless of Cardiac Involvement
2023 · Yuichi Baba, Toru Kubo, et al. · Internal Medicine · 8
PDF
Clinical Features of Heart Failure in Patients With Hypertrophic Cardiomyopathy in a Regional Japanese Cohort ― Results From the Kochi RYOMA Study ―
2022 · Yuya Miyamoto, Toru Kubo, et al. · Circulation Journal · 8
PDF
A retrospective investigation to establish new screening approach for the detection of patients at high risk of Fabry disease in male left ventricular hypertrophy patients
2022 · Toru Kubo, Masashi Amano, et al. · Journal of Cardiology · 8
Importance of Fourth Heart Sound and Preserved Left Atrial Function in Wild-Type Transthyretin Amyloidosis
2024 · Yuri Ochi, Naohito Yamasaki, et al. · ESC Heart Failure · 6
PDF
Transient decrease in the depth of the negative T wave in apical hypertrophic cardiomyopathy is a sign of left anterior descending artery stenosis: a case series
2022 · Naoki Arima, Yuri Ochi, et al. · European Heart Journal - Case Reports · 6
PDF
Echocardiographic Features of Wild-Type Transthyretin Cardiac Amyloidosis From J-Case
2025 · Shuichi Kitada, Yu Kawada, et al. · JACC Asia · 4
PDF
Works count: 70
Citation count: 461
H-index: 13
I10-index: 18
Year
Topic
Type